3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
9
Classical hematology
1
Breast
1
Conditions
Peutz-Jeghers Syndrome
1
Pancreatic Neoplasms
1
Fanconi Anemia, Complementation Group D1
1
Interventions
Tretinoin
2
Gemcitabine
2
venetoclax
1
trametinib
1
talazoparib
1
ruxolitinib
1
regorafenib
1
ponatinib
1
pertuzumab
1
pembrolizumab
1
palbociclib
1
olaparib
1
neratinib
1
lorlatinib
1
lenvatinib
1
isoquercitrin
1
idelalisib
1
ferric carboxymaltose
1
enzalutamide
1
entrectinib
1
enasidenib
1
durvalumab
1
dehydroftorafur
1
darolutamide
1
dacomitinib
1
dabrafenib
1
copanlisib
1
cobimetinib
1
cabozantinib
1
cabazitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
Secretin
×
Classical hematology
×
Clear all
NCT00438906
2021-06-18
CAPS 3
Johns Hopkins University
Completed
200 enrolled